Your session is about to expire
← Back to Search
Behavioural Intervention
24h-Ambulatory Blood Pressure for High Blood Pressure (DIISCCO Trial)
N/A
Waitlist Available
Led By Anil Nigam, MD
Research Sponsored by Anil Nigam
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline and after twelve weeks of intervention
Awards & highlights
DIISCCO Trial Summary
This trial will compare the effects of HIIT vs. hydrochlorothiazide in prehypertensive older adults to see if HIIT can be as effective as medication in lowering blood pressure.
Eligible Conditions
- High Blood Pressure
- Exercise
DIISCCO Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ before and after twelve weeks of intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before and after twelve weeks of intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
24h-Ambulatory Blood Pressure
Secondary outcome measures
Cardiovascular evaluation
Cognitive functions
Flow Mediated Dilatation (FMD)
DIISCCO Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: High Intensity Interval Training (HIIT)Experimental Treatment1 Intervention
For the twelve weeks of intervention, participants will have three training sessions per week. Each session will be done on a cycle ergometer and will last approximately 40 minutes. Participants will be supervised by certified kinesiologists and their training programs will be revised every four weeks.
Group II: HydroChloroThiazideActive Control1 Intervention
For this group, participants have to take a diuretic (12,5 mg of Hydrochlorothiazide) daily prescribed by the doctor of this study, for twelve weeks. Participants should also maintain the same lifestyle habits that they had before the study.
Find a Location
Who is running the clinical trial?
Anil NigamLead Sponsor
Anil Nigam, MDPrincipal InvestigatorMontreal Heart Institute
2 Previous Clinical Trials
50 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger